Invesaro

Stocks CRS Financial statements

Financial statements

CARPENTER TECHNOLOGY CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CARPENTER TECHNOLOGY CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue1,7982,1582,3802,1811,4761,8362,5502,7602,8773,124
Cost of revenue1,4971,7751,935
Gross profit3013824453291150337584769956
Research and development16.919.323.32819.720.424.425.626.127.7
Selling, general and administrative176193203201180175204230243254
Operating income12218924125.3-249-24.9133323522702
Interest expense29.828.32619.832.744.954.15148.437.8
Other non-operating income-21.5-0.80.60.6-8.412.7-6.5-60.5-6.17.6
Pre-tax income70.21602166.1-298-63.172.5212467656
Income tax23.2-28.3494.6-68.3-1416.125.191.3126
Net income471891671.5-230-49.156.4187376530
EBITDA239306363149-125107264458661849
EPS, basic0.993.963.460.02-4.76-1.011.153.757.5010.59
EPS, diluted0.993.923.430.02-4.76-1.011.143.707.4210.52
Shares, basic (weighted)4747.247.748.148.348.548.849.750.250
Shares, diluted (weighted)47.147.648.148.248.348.549.250.350.750.4
Dividend per share0.720.720.800.800.800.800.800.800.800.80

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents66.356.22719328715444.5199316393
Receivables290379384292309382531563576702
Inventory690689788724426496640735794823
Other current assets46.554.937.456.695.686.866.494.179.963.1
Total current assets1,0941,1791,2361,2661,1171,1191,2821,5911,7651,981
Property, plant and equipment1,3171,3131,3661,4981,4581,4211,3841,3351,3591,488
Lease right-of-use assets5234.342.943.93935.430.1
Goodwill263269326290241241241227227227
Intangible assets64.963.367.252.143.135.228.715.29.53.9
Other non-current assets132179188115107110112115118133
Total assets2,8783,0073,1883,2272,9712,9323,0543,2923,4873,838
Accounts payable201215239124142242278264267313
Accrued liabilities140149158158164134181202216207
Deferred revenue9.810.410.512.38.614.41412.35.27.2
Short-term debt55000000
Total current liabilities396363416452306376459466484520
Long-term debt550546551552695692693694695691
Lease liabilities50.335.542.743.638.434.928
Other non-current liabilities47.853.565.11111009899.299.698.591.3
Total liabilities1,6801,5211,6681,7821,5791,6021,6581,6631,6001,611
Total debt605546551552695692693694695691
Paid-in capital285310320321323320328353354357
Retained earnings1,3221,4761,6051,5681,2991,2111,2281,3751,7102,200
Treasury stock-342-339-333-326-317-307-298-289-396-596
Other comprehensive income-343-240-352-398-192-174-143-93.9-67.9-20.4
Shareholders' equity1,1991,4861,5201,4461,3921,3311,3961,6291,8872,228
Total equity1,1991,4861,5201,4461,3921,3311,3961,6291,8872,228
Total liabilities and equity2,8783,0073,1883,2272,9712,9323,0543,2923,4873,838
Shares outstanding46.847.247.547.94848.348.649.849.749.6

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income471891671.5-230-49.156.4187376530
Depreciation and amortization118117122124124131131135139147
Stock-based compensation1317.617.610.910.410.816.419.822.826.4
Deferred income tax41.6-61.116.5-0.4-33.6-3.1-0.4-13.3-17.421.2
Change in receivables-34.6-86.8-5.390.3-14.9-79-145-32.6-1.8-128
Change in inventory-74.60.4-9429.5239-71.9-140-96.7-60.4-28.4
Change in payables42.510.720.1-11022.495.729.2-11-1.417.2
Cash from operations130209232232250614.7275440605
Capital expenditures-98.5-135-180-171-101-91.3-82.3-96.6-154-243
Acquisitions-35.3-13.3-7900
Sales and maturities of investments0.90.72.900
Cash from investing-112-139-245-171-78.9-89.1-82.3-95.9-153-243
Debt repaid0-5500-250-300000-700
Stock issued2.212.93.94.30.50540.913.414.3
Share buybacks0000-102-179
Dividends paid-34.1-34.4-38.6-38.8-39.1-39.2-39.4-40-40.3-40.3
Cash from financing-33.8-78.9-19.4108-76.1-52.8-40.1-23.3-167-287
Exchange rate effect-0.1-12.4-2.3-0.72.7-2-1.1-42.3
Net change in cash-15.7-10.1-29.216694.3-133-11015511677.8
Free cash flow31.874.252.160.4150-85.3-67.6178286362
Interest paid27.729.527.62728.240.550.949.248.448.2
Income taxes paid-33.333.727.529.82.1-46.19.962.893.684.8

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $396.84 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin30.6%Gross profit / revenue.
Operating margin22.5%Operating income / revenue.
EBITDA margin27.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin21.0%Pre-tax income / revenue.
Net margin17.0%Net income / revenue.
FCF margin11.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin19.4%Cash from operations / revenue.
Effective tax rate19.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)25.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)14.5%Net income / average total assets.
Return on invested capital (ROIC)23.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue0.9%Research and development expense / revenue.
SG&A / revenue8.1%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue7.8%Capital expenditures / revenue.
D&A / revenue4.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y8.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y16.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y24.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y41.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y294.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y34.5%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y74.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y28.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y47.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y40.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y111.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y41.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y109.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y37.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y245.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y19.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y26.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y19.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y0.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y18.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y16.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y10.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y7.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.81xCurrent assets / current liabilities.
Quick ratio2.11x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.76x(Cash + short-term investments) / current liabilities.
Debt / equity0.31xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets18.0%Total debt / total assets.
Liabilities / assets42.0%Total liabilities / total assets.
Net debt$297.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.35xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage18.6xOperating income / interest expense.
Working capital$1.46BCurrent assets - current liabilities.
Goodwill and intangibles / assets6.0%(Goodwill + intangible assets) / total assets.
Tangible book value$2.00BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.85xRevenue / average total assets.
Fixed asset turnover2.19xRevenue / average property, plant and equipment.
Receivables turnover4.89xRevenue / average receivables.
Days sales outstanding75 days365 x average receivables / revenue.
FCF conversion68.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow40.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$10.52Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$10.59Net income per basic share, as reported (split-adjusted).
Revenue per share$61.99Revenue / diluted weighted shares.
FCF per share$7.19Free cash flow / diluted weighted shares.
Operating cash flow per share$12.00Cash from operations / diluted weighted shares.
Book value per share$44.91Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$40.24Tangible book value / shares outstanding.
Cash per share$7.93(Cash + short-term investments) / shares outstanding.
Dividend per share$0.80Dividend declared per common share (paid, when declared is not tagged).
Payout ratio7.6%Dividends paid / net income, when net income is positive.
Dividends / FCF11.1%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF49.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$19.67BShare price x shares outstanding.
Enterprise value$19.96BMarket cap + total debt - cash - short-term investments.
P/E37.1xMarket cap / net income. Only when net income is positive.
P/S6.29xMarket cap / revenue.
P/B8.83xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book9.85xMarket cap / tangible book value, when positive.
P/FCF54.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF32.5xMarket cap / cash from operations, when positive.
EV/Sales6.39xEnterprise value / revenue.
EV/EBIT28.4xEnterprise value / operating income, when both are positive.
EV/EBITDA23.5xEnterprise value / EBITDA, when both are positive.
EV/FCF55.1xEnterprise value / free cash flow, when both are positive.
FCF yield1.8%Free cash flow / market cap.
Earnings yield2.7%Net income / market cap (the inverse of P/E).
Dividend yield0.2%Dividends paid over the period / market cap.
Shareholder yield1.1%(Dividends paid + share buybacks) / market cap.
PEG0.34xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was CARPENTER TECHNOLOGY CORP's revenue in fiscal 2026?

CARPENTER TECHNOLOGY CORP reported revenue of $3.12B for fiscal 2026, 8.6% higher than the year before.

Was CARPENTER TECHNOLOGY CORP profitable in fiscal 2026?

Yes. Net income was $529.8M, a net margin of 17%.

How much free cash flow did CARPENTER TECHNOLOGY CORP generate in fiscal 2026?

Cash from operations of $605.0M minus capital expenditures of $242.7M left free cash flow of $362.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CARPENTER TECHNOLOGY CORP